Walts Alan Edmund has filed 7 insider transactions across 1 company since January 2024.
Most recent transaction: a option exercise of 1875 shares of Eloxx Pharmaceuticals, Inc. ($ELOX) on January 24, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 24, 2026 | Eloxx Pharmaceuticals, Inc. | $ELOX | Walts Alan Edmund | Not found | M | Restricted Stock Units | 1875 | $0.00 | 1,875.0000 | 12,347,495 | 50.00% | 0.02% |
| Jan. 24, 2026 | Eloxx Pharmaceuticals, Inc. | $ELOX | Walts Alan Edmund | Not found | M | Common Stock | 1875 | $0.00 | 15,567.0000 | 12,347,495 | 13.69% | 0.02% |
| Sept. 19, 2025 | Eloxx Pharmaceuticals, Inc. | $ELOX | Walts Alan Edmund | Not found | A | Stock Option (Right to Buy) | 395680 | $0.00 | 395,680.0000 | 3,758,804 | 9999.99% | 10.53% |
| Jan. 24, 2025 | Eloxx Pharmaceuticals, Inc. | $ELOX | Walts Alan Edmund | Director | M | Restricted Stock Units | 3750 | $0.00 | 3,750.0000 | 3,758,804 | 50.00% | 0.10% |
| Jan. 24, 2025 | Eloxx Pharmaceuticals, Inc. | $ELOX | Walts Alan Edmund | Director | M | Common Stock | 3750 | $0.00 | 16,692.0000 | 3,758,804 | 28.98% | 0.10% |
| Oct. 16, 2024 | Eloxx Pharmaceuticals, Inc. | $ELOX | Walts Alan Edmund | Director | A | Common Stock | 12000 | $0.00 | 12,942.0000 | 2,570,620 | 1273.89% | 0.47% |
| Jan. 24, 2024 | Eloxx Pharmaceuticals, Inc. | $ELOX | Walts Alan Edmund | Director | A | Restricted Stock Units | 7500 | $0.00 | 7,500.0000 | 2,570,620 | 9999.99% | 0.29% |